OPK

OPKO HEALTH, INC.

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

OPKOPKO Health, Inc.
0Calm
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants
Signing up patientsPhase 240 patientsMain results: Oct 2027

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

2 sales (2 not pre-planned) · 0 purchases

PAGANELLI JOHN ABoard member · Nov 5, 2026Sold 4,426 sharesabout $8 thousand · not pre-planned
PAGANELLI JOHN ABoard member · Nov 5, 2026Sold 9,175 sharesabout $17 thousand · not pre-planned

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.